The 43-kDa glycoprotein of Paracoccidioides brasiliensis is the major diagnostic antigen of paracoccidioidomycosis, the prevalent systemic mycosis of Latin America, Apart from eliciting high antibody titers, gp13 is also immunodominant in delayed-type hypersensitivity reactions in infected animals and humans, The cellular immune response in mice to gp43 administered in complete Freund's adjuvant involves CD4(+) Th-l lymphocytes, secreting gamma interferon (IFN-gamma) and interleukin 2 (IL-2) but not IL-4 and IL-10, The T-cell epitope of this antigen was mapped to a 15-amino-acid peptide (P10) based on lymphoproliferations with primed cells from three different haplotypes and on a computer-assisted protein analysis, The structural requiremen...
Glycoprotein gp43 is an immunodominant diagnostic antigen for paracoccidioidomycosis caused by Parac...
Paracoccidioidomycosis is a granulomatous pulmonary infection that is generally controlled by chemot...
One of the major drawbacks limiting the use of synthetic peptide vaccines in genetically distinct po...
The 43 kDa glycoprotein (gp43) of Paracoccidioides brasiliensis is the major diagnostic antigen of p...
A glicoproteína de 43 kDa do Paracoccidioides brasiliensis é o principalantígeno diagnóstico da para...
The 43,000-Da glycoprotein (gp43) of Paracoccidioides brasiliensis is an immunodominant antigen for ...
The protective role of specific antibodies against Paracoccidioides brasiliensis is controversial. I...
Paracoccidioidomycosis (PCM) is a systemic mycosis endemic in Latin America, with a high prevalence ...
Paracoccidioidomycosis is a systemic mycosis endemic in Latin America, with a high prevalence in Bra...
The protective role of specific antibodies against Paracoccidioides brasiliensis is controversial. i...
Gp43, the major 43-kDa antigenic glycoprotein of Paracoccidioides brasiliensis, or its 15-amino acid...
Paracoccidioidomycosis (PCM) endemic in Latin America, is a progressive systemic mycosis caused by P...
Chemotherapy is the basis of treatment of paracoccidioidomycosis in its various forms. Depending on ...
Chemotherapy is the basis of treatment of paracoccidioidomycosis in its various forms. Depending on ...
Paracoccidioidomycosis is a granulomatous pulmonary infection that is generally controlled by chemot...
Glycoprotein gp43 is an immunodominant diagnostic antigen for paracoccidioidomycosis caused by Parac...
Paracoccidioidomycosis is a granulomatous pulmonary infection that is generally controlled by chemot...
One of the major drawbacks limiting the use of synthetic peptide vaccines in genetically distinct po...
The 43 kDa glycoprotein (gp43) of Paracoccidioides brasiliensis is the major diagnostic antigen of p...
A glicoproteína de 43 kDa do Paracoccidioides brasiliensis é o principalantígeno diagnóstico da para...
The 43,000-Da glycoprotein (gp43) of Paracoccidioides brasiliensis is an immunodominant antigen for ...
The protective role of specific antibodies against Paracoccidioides brasiliensis is controversial. I...
Paracoccidioidomycosis (PCM) is a systemic mycosis endemic in Latin America, with a high prevalence ...
Paracoccidioidomycosis is a systemic mycosis endemic in Latin America, with a high prevalence in Bra...
The protective role of specific antibodies against Paracoccidioides brasiliensis is controversial. i...
Gp43, the major 43-kDa antigenic glycoprotein of Paracoccidioides brasiliensis, or its 15-amino acid...
Paracoccidioidomycosis (PCM) endemic in Latin America, is a progressive systemic mycosis caused by P...
Chemotherapy is the basis of treatment of paracoccidioidomycosis in its various forms. Depending on ...
Chemotherapy is the basis of treatment of paracoccidioidomycosis in its various forms. Depending on ...
Paracoccidioidomycosis is a granulomatous pulmonary infection that is generally controlled by chemot...
Glycoprotein gp43 is an immunodominant diagnostic antigen for paracoccidioidomycosis caused by Parac...
Paracoccidioidomycosis is a granulomatous pulmonary infection that is generally controlled by chemot...
One of the major drawbacks limiting the use of synthetic peptide vaccines in genetically distinct po...